Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133612) titled 'Clinical research on molecular probes targeting acidic prostatic phosphatase (ACP3)' on Sept. 29.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Guilin Medical University

Condition: prostate cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-08

Target Sample Size: 68Ga-ACP3 group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=345019

Published by HT Digital Content Services with permission from Health Daily Digest....